公开(公告)号：US20240076301A1

公开(公告)日：2024-03-07

申请号：US18268795

申请日：2021-12-22

Applicant: Pfizer Inc. ,  EFFECTOR THERAPEUTICS, INC.

Inventor： Kapildev Kashmirilal Arora ,  Wesley Dewitt Clark ,  David Malcolm Crowe ,  Jason Gray

IPC: C07D519/00

CPC classification number: C07D519/00

Abstract: The present invention relates to solid forms of 7-(5-chloro-2-(3-(5-cyano-6-(1-(3,3-difluorocyclobutyl)piperidin-4-yl)(methyl)amino)-2-methyl-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl)prop-1-yn-1-yl)phenyl)-N-(methylsulfonyl)thieno[3,2-b]pyridine-3-carboxamide, to pharmaceutical compositions comprising such solid forms, and to methods of using such solid forms and pharmaceutical compositions for the treatment of cancer.